Company Filing History:
Years Active: 2013
Title: Mikaela Recknagel: Innovator in Pharmaceutical Processes
Introduction
Mikaela Recknagel is a talented inventor based in Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. Her work is characterized by a focus on complex chemical structures and their applications in medicine.
Latest Patents
Mikaela Recknagel currently holds no patents. However, she has developed a notable process for preparing a specific compound, which is described as follows: A Process For Preparing [1S-[1-Alpha,2-Alpha,3-Beta(1S*,2R*)5-Beta]]-3-[7-[2-(3,4-Difluorophenyl)-Cyclopropylamino]-5-(propylthio)-3H-1,2,3-Triazolo[4,5-D]pyrimidin-3-Yl]-5-(2-Hydroxyethoxy)cyclopentane-1,2-Diol And To Its Intermediates. This invention is directed towards a process for preparing a complex chemical structure, which has potential applications in the pharmaceutical industry.
Career Highlights
Mikaela is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves research and development, where she applies her expertise in chemistry to advance drug formulation processes. Her contributions are vital to the ongoing efforts of AstraZeneca in delivering innovative therapies to patients.
Collaborations
Mikaela has collaborated with several professionals in her field, including Rhony Aufdenblatten and Martin Hans Bohlin. These collaborations enhance her research and development efforts, allowing for a more comprehensive approach to pharmaceutical innovation.
Conclusion
Mikaela Recknagel is a promising inventor in the pharmaceutical sector, with a focus on innovative processes for drug preparation. Her work at AstraZeneca AB and her collaborations with other professionals highlight her commitment to advancing medical science. Her contributions are expected to have a lasting impact on the industry.